Blog

Perspectives in Breast and Colorectal Cancer Research


NSABP Foundation

Dr. Charles Geyer discusses the KATHERINE Trial with Dr. Jame Abraham

In this MDEdge Blood & Cancer podcast, Charles E. Geyer, MD, of Virginia Commonweath University joins guest host Jame Abraham, MD, of the Cleveland Clinic to discuss the KATHERINE trial and its impact on the treatment of HER2-positive breast cancer.
Previous Article Dr. Charles Geyer discusses the NSABP B-59/GBG 96-GeparDouze trial
Print
1150

Name:
Email:
Subject:
Message:
x